Diagnostic criteria in multiple sclerosis: Headed in the right direction but still a ways to go

Annals of Neurology

Volumn 69, Issue 2, 2011, Pages 234-236

  Rudick, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCE IMPAIRMENT; CLINICAL FEATURE; DISEASE CLASSIFICATION; EDITORIAL; FATIGUE; HUMAN; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARESTHESIA; PREDICTION; PRIORITY JOURNAL;

DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED;

EID: 79952524340     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22388     Document Type: Editorial

References (21)

1. Schumacher GA, Beebe GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552-568.
2. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231. (Pubitemid 13158528)
3. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-185. (Pubitemid 18036832)
4. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120 (pt 11): 2059-2069. (Pubitemid 27493740)
5. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38: 1822-1825. (Pubitemid 19004571)
6. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
7. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005; 58: 840-846. (Pubitemid 41746873)
8. Hawkes CH, Giovannoni G,. The McDonald Criteria for Multiple Sclerosis: time for clarification. Mult Scler 2010; 16: 566-575.
9. Polman C, Reingold S, Branwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
10. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 702-706. (Pubitemid 30210434)
11. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006; 77: 830-833. (Pubitemid 44023177)
12. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007; 6: 677-686. (Pubitemid 47064439)
13. Gout O, Lebrun-Frenay C, Labauge P, et al. Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event. J Neurol Neurosurg Psychiatry. 2010 Nov 19 [Epub ahead of Print].
14. Morrow SA, Fraser JA, Nicolle D, et al. Predicting conversion to MS-the role of a history suggestive of demyelination. Can J Neurol Sci 2010; 37: 488-491.
15. Lublin FD, Reingold SC,. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-911. (Pubitemid 26134623)
16. Hawker K, O'Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009; 66: 460-471.
17. Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008; 358: 676-688. (Pubitemid 351240747)
18. Kappos L, Weinshenker B, Pozzilli C, et al. Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology 2004; 63: 1779-1787. (Pubitemid 39532369)
19. Moore F, Okuda DT,. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009; 73: 1714.
20. Lebrun C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 2009; 66: 841-846.
21. Geurts JJ,. Is progressive multiple sclerosis a gray matter disease? Ann Neurol 2008; 64: 230-232.